SPS
VYGR icon

Susquehanna Portfolio Strategies’s Voyager Therapeutics VYGR Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
123,198
+33,484
+37% +$127K 0.01% 689
2026
Q1 		$346K Buy
+89,714
New +$353K 0.01% 825

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Susquehanna Portfolio Strategies's VYGR Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Voyager Therapeutics (VYGR) stake by 37% in Q2 2026, buying an estimated $127K and bringing the position to 123,198 shares worth $431K. The position accounts for 0.01% of the portfolio, ranked #689.

Susquehanna Portfolio Strategies first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Susquehanna Portfolio Strategies held 123,198 shares of Voyager Therapeutics worth $431K as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 33,484 Voyager Therapeutics shares in Q2 2026, an estimated $127K.
  • Voyager Therapeutics made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #689 holding.
  • Susquehanna Portfolio Strategies first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.